Clinical Trial Update: Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing azacitidine alone versus azacitidine with vorinostat in patients with acute myeloid leukemia or high-risk myelodysplastic syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• High-risk Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Vorinostat (vorinostat)

Snippet

Sponsor: University of Birmingham | Conditions: Leukemia, Myeloid, Acute | Phase 2 | Status: COMPLETED